Authors
Begum Arca, Yasemin Sanli
Published in
Magnetic resonance imaging clinics of North America. Volume 35. Issue 1. Pages 91-99. Epub Oct 14, 2026.
Abstract
This review provides a comprehensive overview of prostate-specific membrane antigen (PSMA) PET/computed tomography (CT) in the management of prostate cancer. It explores the physiologic biodistribution of various 68 Ga and 18F-labeled tracers, standardized imaging protocols, and essential diagnostic criteria. We detail the modality's transformative role in primary staging, localizing biochemical recurrence at low prostate-specific antigen levels, and selecting patients for radioligand therapy. By highlighting critical diagnostic pitfalls and the emerging challenge of PSMA-negative disease, this article equips clinicians with the practical knowledge necessary to integrate PSMA PET/CT effectively into multidisciplinary oncology practice.
PMID:
43039506
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0